Linezolid
Linezolid is an organofluorine compound that consists of 1,3-oxazolidin-2-one bearing an N-3-fluoro-4-(morpholin-4-yl)phenyl group as well as an acetamidomethyl group at position 5. A synthetic antibacterial agent that inhibits bacterial protein synthesis by binding to a site on 23S ribosomal RNA of the 50S subunit and prevents further formation of a functional 70S initiation complex. It has a role as an antibacterial drug and a protein synthesis inhibitor. It is an oxazolidinone, a member of morpholines, an organofluorine compound and a member of acetamides.
Supplier | CD Formulation |
---|---|
Product # | PAP-0042 |
CAS # | 605-416-1 |
Pricing | , Inquire for price |
product1 | Antibacterial, Anti-inflammatory and Antiviral Series |
Molecular Formula | C16H20FN3O4 |
CAS Number | 165800-03-3 |
Category | Antibacterial, anti-inflammatory and antiviral |
Standard | Internal Control/USP |
Color | white to off-white |
Physical State | powder |
Solubility | DMSO: >20mg/mL |
Storage | room temp |
Applications | Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). |
Boiling Point | 585.5±50.0 °C(Predicted) |
Melting Point | 176-178℃ |
Density | 1.302±0.06 g/cm3(Predicted) |
Product Description | Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). |
Molecular Weight (g/mol) | 337.35 |
MDL number | MFCD00937825 |
InChI Key | TYZROVQLWOKYKF-ZDUSSCGKSA-N |
Hazard Codes | Xn |
WGK Germany | 3.0 |
RTECS | AC2720000 |
HS Code | 29419000.0 |
HazardClass | 20/21/22 |